Conference Calendar

March 14-18 - American Association of Orthopaedic Medicine Annual Meeting 2017

March 14-December 31 - Canaccord Genuity Musculoskeletal Conference

Complete Calendar »

Earnings Calendar

No Upcoming Events Scheduled
Complete Calendar »

Read our research via:
email art

Weekly Email

rss art


app icon


app store icon


Orthopedic and Dental Industry News

April 2006

Orthopedic News Roundup 27-Apr-06 BY HUYEN NGUYEN, APRIL 27, 2006

Appointment: Stryker Corp. appointed three officers to the company: Luciano Cattani, Vice President, Group President, International; Elizabeth A. Staub, Vice President of Regulatory Affairs and Quality Assurance, Stryker Corporation and Bronwen R. Taylor, Chief Compliance Officer, Stryker Corporation. Mr. Cattani... more

1Q:06 Preliminary Earnings Summary BY HUYEN NGUYEN, APRIL 27, 2006

The first group of orthopedic companies reported their 1Q:06 this week and took in $5.3 billion so far. The total aggregated revenues for the quarter were up by 7% from $4.9 billion in 1Q:05. The industry netted $637.8 million, a... more

LifeCell Skyrockets BY JOHN MCCORMICK, APRIL 26, 2006

In the swarm of public earnings reports for the first quarter, we thought LifeCell's results were particularly newsworthy. Thanks to the Company's AlloDerm Regenerative Tissue Matrix which grew at an astounding 69% year-over-year ($25.3 million in 1Q:06 compared to $14.9... more

Zimmer and HCA Make Up BY DAVID KRESSEL, APRIL 25, 2006

Our regular readers will remember that a few months ago, Zimmer and HCA had an unusually public fight. To briefly review, HCA entered into volume discount contracts with Zimmer, Stryker and DePuy. At year end, the implant companies reported HCA... more

The Proposed Change in Medicare Inpatient Reimbursement Expected to Impact Profitability of Specialty Hospitals BY MARTIN GOLD, APRIL 24, 2006

[Editor's note: We welcome regulatory expert Martin Gold as a guest blogger. See his profile here.] The recently published proposed change in inpatient Medicare payment is expected to have a significant financial affect on hospitals that specialize in cardiac and... more

1Q:06 Conference Calls Dial-in & Webcast BY HUYEN NGUYEN, APRIL 24, 2006

Below is the table of company earnings conference calls and webcast for the investment community. We also have replay information for companies that have already reported. Make sure you remember to mark your calendar for April 26 & 27, most... more

Orthopedic News Roundup 20-Apr-06 BY HUYEN NGUYEN, APRIL 20, 2006

Many orthopedic companies will be reporting their 1Q:06 results in the next few weeks. The table below provides a listing of conference call dial-in numbers and webcasts for the investment community. How the overall orthopedic industry fared in the first... more

Fewer Deaths: Good for Orthopedics BY JOHN MCCORMICK, APRIL 19, 2006

Today, the National Center for Health Statistics issued a draft finding that the annual number of deaths in the U.S. dropped by nearly 50,000, or 2%, in 2004 which represents the biggest decline since World War II. The preliminary number... more

Medtronic Countersues Kyphon BY DAVID KRESSEL, APRIL 19, 2006

As we reported in March, Kyphon and Dr. Harvinder Sandhu filed an IP suit against Medtronic, and now Medtronic has parried with its own lawsuit. Medtronic has countersued Kyphon, claiming Kyphoplasty infringes on 3 patents relating to balloons for use... more

Turnover at the Top BY JOHN CHOPACK, APRIL 18, 2006

During the previous 2 years 10 new top executives have been appointed within the orthopedic sector. The changes have occurred at the largest companies including Stryker, DePuy and Biomet, as well as at some of the smallest including OrthoLogic and... more

FDA Approves CORTOSS Study Modifications BY JOHN MCCORMICK, APRIL 17, 2006

This morning Orthovita announced that the FDA has approved its request to modify it's CORTOSS study design. The prospective randomized controlled multi-center IDE study is underway in the U.S. and is designed to demonstrate that CORTOSS is safe and effective... more

CMS Proposed Rule for Orthopedics Procedures for FY 2007 BY HUYEN NGUYEN, APRIL 17, 2006

Last week The Centers for Medicare & Medicaid Services (CMS) issued a report on a revised proposed rulemaking of the Inpatient Prospective Payment System (IPPS). The proposed rule highlights changes and updates for Diagnosis Related Groups (DGRs) in orthopedic surgeries:... more

Orthopedic News Roundup 13-Apr-06 BY HUYEN NGUYEN, APRIL 13, 2006

The Centers for Medicare & Medicaid Services (CMS) issued a report today on a revised propose rulemaking of the Inpatient Prospective Payment System (IPPS). The propose rule highlights changes and updates for Diagnosis Related Groups (DGRs) in orthopedic surgeries: including... more

Medtronic Bets On Itself BY DAVID KRESSEL, APRIL 12, 2006

Medtronic, parent of orthopedic giant Sofamor Danek, has decided to rejigger its capital structure. It is offering $4 billion in convertible bonds, and using $2.5 billion of the proceeds to repurchase common stock, which comes out to about 4% of... more

Is Biomet Really for Sale? BY HUYEN NGUYEN, APRIL 7, 2006

Biomet was founded twenty-nine years ago with a superb management team including Dane Miller, Ph.D. Dr. Miller became the iconic figure of Biomet and has led the Company on a very successful run with a current market capitalization of $9.5... more

HealthpointCapital's Resources for Orthopedists BY HUYEN NGUYEN, APRIL 6, 2006

We think the following sites have educational and resourceful information for orthopedic professionals. Contact us if you think a site should be added. This list also contains images of the human anatomy as well as orthopedic injuries and conditions. MEDLINE... more

Orthopedic News Roundup 6-Apr-06 BY HUYEN NGUYEN, APRIL 6, 2006

The announcement of Biomet hiring investment bank Morgan Stanley, sent its stock price up 11% in one day. With news of Dane Miller resigning and the Company hiring a banker, there were many speculations suggesting Biomet is for sale. However,... more

OrthoLogic's CEO Resigned BY HUYEN NGUYEN, APRIL 6, 2006

After divesting its bone growth stimulation business to dj Orthopedics for $93 million in cash, OrthoLogic ("OLGC") became a full-time biotechnology company dedicated to research, development and commercialization of its proprietary products, Chrysalin® and AZX100. The past two years have... more

Impact of Direct-to-Consumer Advertising BY MATTHEW JAFFE, APRIL 6, 2006

Kevin Bozic, MD of UCSF presented the impact of Direct to Consumer Advertising (DTCA) in Orthopedics during the Health Policy Symposium at AAOS. Since the FDA issued a draft guidance for consumer directed advertisements in the late 90's, first pharmaceutical... more

Medical Device Trade in Foreign Markets -- Investigation BY HUYEN NGUYEN, APRIL 5, 2006

The U.S. International Trade Commission (ITC) issued a press release yesterday announcing the launch of a fact-finding investigation into conditions affecting U.S. trade of medical devices and equipment in principal foreign markets, particularly the Japanese market. The House Ways and... more

Adverse Selection and Employer Based Insurance Markets [EDITORIAL] BY JOHN MCCORMICK, APRIL 5, 2006

Any microeconomics 101 course worth its salt will try to provide examples of market failure. The most potent market failure arguments can tied to real world problems of information economics where one of the more famous examples used is "adverse... more

Ossur Product Recall BY HUYEN NGUYEN, APRIL 4, 2006

Last week Ossur announced product recall on one of its prosthetic knee lines. The Total Knee® 1100, 1900, 2000 and 2100 models were being recalled due to some faulty pins that were fixated at the axis of the knee. The... more

Complete Archive